Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort

被引:25
|
作者
Gausman, Valerie [1 ]
Kandel, Pujan [2 ]
Van Riet, Priscilla A. [3 ]
Moris, Maria [2 ]
Kayal, Maia [4 ]
Do, Catherine [5 ]
Poneros, John M. [4 ]
Sethi, Amrita [4 ]
Gress, Frank G. [4 ]
Schrope, Beth A. [6 ]
Luk, Lyndon [7 ]
Hecht, Elizabeth [7 ]
Jovani, Manol [8 ,9 ]
Bruno, Marco J. [3 ]
Cahen, Djuna L. [3 ]
Wallace, Michael B. [2 ]
Gonda, Tamas A. [4 ]
机构
[1] NYU Langone Med Ctr, Dept Med, New York, NY USA
[2] Mayo Clin, Dept Gastroenterol & Hepatol, Jacksonville, FL 32224 USA
[3] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[4] Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY USA
[5] Columbia Univ, Med Ctr, Herbert Irving Canc Ctr, New York, NY USA
[6] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA
[7] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA
[8] Massachusetts Gen Hosp, Div Gastroenterol, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA
[9] Harvard Med Sch, Boston, MA 02114 USA
关键词
pancreatic cysts; surveillance; low risk; disease progression; risk factors; INTERNATIONAL-CONSENSUS-GUIDELINES; PANCREATIC-CANCER; CYST-SIZE; NATURAL-HISTORY; MAIN-DUCT; MANAGEMENT; MALIGNANCY; MUTATIONS; DIAGNOSIS; METAANALYSIS;
D O I
10.1097/MPA.0000000000001027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Our aim was to identify baseline characteristics associated with disease progression and malignant transformation in low-risk suspected intraductal papillary mucinous neoplasms (IPMNs). Methods This is a retrospective cohort study of prospectively maintained databases of pancreatic cysts at 3 international, academic institutions. Five hundred fifty-nine adult patients with clinically suspected asymptomatic IPMN evaluated by radiologic studies or endoscopic ultrasound between 2003 and 2013 without worrisome features and under surveillance for 12 months or longer were included. We evaluated the relationship of baseline demographics and cyst features to disease progression (size increase, development of worrisome features, or high-grade dysplasia/cancer). Results After a median of 44 months follow-up, 269 (48%) patients experienced cyst size increase, 68 (12%) developed worrisome features, and 11 (2%) developed high-grade dysplasia/cancer. In multivariable Cox-regression analysis, no baseline characteristics were associated with size increase. An initial cyst size of 2 cm or greater, multifocality, history of prostate cancer, and smoking were the strongest predictors of development of new worrisome features. Univariable analysis found male sex, diabetes, and recent weight loss associated with development of high-grade dysplasia/cancer. Conclusions Our study demonstrates that low-risk suspected IPMNs carry a small but clinically relevant risk of disease progression and provides data on baseline characteristics that may help in risk stratification.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 50 条
  • [1] Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms
    Kayal, Maia
    Luk, Lyndon
    Hecht, Elizabeth M.
    Do, Catherine
    Schrope, Beth A.
    Chabot, John A.
    Gonda, Tamas A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (02) : 320 - 326
  • [2] Assessing Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
    Lohr, J. -Matthias
    Del Chiaro, Marco
    JAMA NETWORK OPEN, 2020, 3 (11)
  • [3] Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
    Capurso, Gabriele
    Crippa, Stefano
    Vanella, Giuseppe
    Traini, Mariaemilia
    Zerboni, Giulia
    Zaccari, Piera
    Belfiori, Giulio
    Gentiluomo, Manuel
    Pessarelli, Tommaso
    Petrone, Maria Chiara
    Campa, Daniele
    Falconi, Massimo
    Arcidiacono, Paolo Giorgio
    JAMA NETWORK OPEN, 2020, 3 (11) : E2022933
  • [4] Long Term Surveillance and Risk of Progression of Low-Intermediate Risk Intraductal Papillary Mucinous Neoplasms
    Kayal, M.
    Luk, L.
    Gress, F.
    Sethi, A.
    Poneros, J.
    Hecht, E.
    Gonda, T.
    PANCREAS, 2015, 44 (08) : 1386 - 1386
  • [5] Extended Surveillance of Low-Risk Branch Duct Intraductal Papillary Mucinous Neoplasms: When Is It Time to Stop?
    Youssef, Fady
    Majumder, Shounak
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1427 - 1429
  • [6] Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer
    Lauri, Gaetano
    Apadula, Laura
    Archibugi, Livia
    Lazzano, Pilar
    Pisani, Ruggero Ponz de Leon
    Cobreros, Marina
    Tacelli, Matteo
    Marchegiani, Giovanni
    Crippa, Stefano
    Falconi, Massimo
    Arcidiacono, Paolo Giorgio
    Capurso, Gabriele
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (01) : 38 - 43
  • [7] Long Term Surveillance and Risk of Progression of Low-Intermediate Risk Branch Duct Intraductal Papillary Mucinous Neoplasms
    Kayal, Maia
    Luk, Lyndon
    Felgueroso, Maria Moris
    Wallace, Michael B.
    Sethi, Amrita
    Poneros, John M.
    Gress, Frank G.
    Hecht, Elizabeth
    Gonda, Tamas A.
    GASTROENTEROLOGY, 2016, 150 (04) : S503 - S504
  • [8] Risk factors for malignant progression of intraductal papillary mucinous neoplasms
    Moris, Maria
    Raimondo, Massimo
    Woodward, Timothy A.
    Skinner, Verna
    Arcidiacono, Paolo G.
    Petrone, Maria C.
    De Angelis, Claudio
    Manfre, Selene
    Fusaroli, Pietro
    Wallace, Michael B.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) : 495 - 501
  • [9] The Cost of Intraductal Papillary Mucinous Neoplasms Surveillance
    Shah, Shawn L.
    Gordon, Stuart R.
    Gardner, Timothy B.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S13 - S13
  • [10] CYST SIZE AND GROWTH AS PREDICTORS OF MALIGNANT TRANSFORMATION IN LOW-RISK INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS: A SYSTEMATIC REVIEW
    Meziani, Jihane
    Sprij, Marloes
    Fuhler, Gwenny
    Bruno, Marco J.
    Cahen, Djuna
    GASTROENTEROLOGY, 2024, 166 (05) : S1341 - S1341